BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8977245)

  • 1. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia.
    Le Bousse-Kerdilès MC; Chevillard S; Charpentier A; Romquin N; Clay D; Smadja-Joffe F; Praloran V; Dupriez B; Demory JL; Jasmin C; Martyré MC
    Blood; 1996 Dec; 88(12):4534-46. PubMed ID: 8977245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis.
    Le Bousse-Kerdilès MC; Martyré MC
    Ann Hematol; 1999 Oct; 78(10):437-44. PubMed ID: 10550553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
    Xiao M; Oppenlander BK; Dooley DC
    Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia.
    Steunou V; Le Bousse-Kerdilès MC; Colin-Micouin A; Clay D; Chevillard S; Martyré MC;
    Leukemia; 2003 Oct; 17(10):1998-2006. PubMed ID: 14513050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis.
    Le Bousse-Kerdilès MC; Martyré MC;
    Pathol Biol (Paris); 2001 Mar; 49(2):153-7. PubMed ID: 11317961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mast cell-committed progenitors present in human umbilical cord blood.
    Kempuraj D; Saito H; Kaneko A; Fukagawa K; Nakayama M; Toru H; Tomikawa M; Tachimoto H; Ebisawa M; Akasawa A; Miyagi T; Kimura H; Nakajima T; Tsuji K; Nakahata T
    Blood; 1999 May; 93(10):3338-46. PubMed ID: 10233886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts.
    Oh IH; Lau A; Eaves CJ
    Blood; 2000 Dec; 96(13):4160-8. PubMed ID: 11110687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.
    Snoeck HW; Weekx S; Moulijn A; Lardon F; Lenjou M; Nys G; Van Ranst PC; Van Bockstaele DR; Berneman ZN
    J Exp Med; 1996 Feb; 183(2):705-10. PubMed ID: 8627186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
    Manz CY; Nissen C; Wodnar-Filipowicz A
    Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?
    Bilhou-Nabéra C; Brigaudeau C; Clay D; Andrieux J; Lai JL; Brouty-Boyé D; Vignon C; Gharbi MJ; Le Bousse-Kerdilès MC; Praloran V;
    Blood; 2003 Aug; 102(4):1551-2. PubMed ID: 12900353
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotype and progeny of primitive adherent human hematopoietic progenitors.
    Gordon MY; Lewis JL; Grand FH; Marley SB; Goldman JM
    Leukemia; 1996 Aug; 10(8):1347-53. PubMed ID: 8709641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N; Hatzfeld J; Kisselev S; Monier MN; Ducos K; Cardoso A; Batard P; Hatzfeld A
    Stem Cells; 2000; 18(2):102-11. PubMed ID: 10742382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
    Chou JM; Li CY; Tefferi A
    Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of c-kit expression and cell cycle regulation by transforming growth factor-beta in CD34+ CD38- human bone marrow cells.
    Morita N; Yamamoto M; Tanizawa T
    Eur J Haematol; 2003 Nov; 71(5):351-8. PubMed ID: 14667198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
    Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
    Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
    Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
    Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.
    Oez S; Trautmann U; Smetak M; Birkmann J; al salemeh S; Gebhart E; Gallmeier WM
    Ann Hematol; 1996 May; 72(5):307-16. PubMed ID: 8645743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.